Management of acute coronary syndromes: an update.
作者信息
Fox Keith A A
机构信息
Cardiovascular Research Unit, Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK.
出版信息
Heart. 2004 Jun;90(6):698-706. doi: 10.1136/hrt.2003.020321.
Abstract
摘要
相似文献
1
Management of acute coronary syndromes: an update.
Heart. 2004 Jun;90(6):698-706. doi: 10.1136/hrt.2003.020321.
2
[Update coronary artery disease: important progresses in acute and chronic therapy].
MMW Fortschr Med. 2012 Mar 22;154(5):58-60. doi: 10.1007/s15006-012-0308-8.
3
Contemporary management of coronary heart disease.
J R Coll Physicians Edinb. 2010 Mar;40(1):44-7; quiz 48. doi: 10.4997/JRCPE.2010.122.
4
[Acute coronary syndromes without ST-elevation -- treatment].
Dtsch Med Wochenschr. 2003 Feb 7;128(6):273-6. doi: 10.1055/s-2003-37072.
5
Combination therapy: management of acute myocardial infarction in the new millennium.
J Emerg Med. 2000 Oct;19(3 Suppl):33S-38S. doi: 10.1016/s0736-4679(00)00253-5.
6
The evolving algorithm concerning higher-risk PCI (TEACH-PCI). Introduction.
Rev Cardiovasc Med. 2007;8 Suppl 3:S1-2.
7
Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
Int J Cardiol. 2007 Jun 25;119(1):65-72. doi: 10.1016/j.ijcard.2006.07.058. Epub 2006 Oct 12.
8
The role of percutaneous revascularization in the treatment of ischemic heart disease: insights from published reports and randomized clinical trials.
Chest. 1997 Sep;112(3):805-21. doi: 10.1378/chest.112.3.805.
9
Is it naive to load only clopidogrel-naive patients prior to PCI?
Eur Heart J. 2010 Jun;31(11):1298-300. doi: 10.1093/eurheartj/ehq082. Epub 2010 Apr 2.
引用本文的文献
1
Presentation, management, and early outcomes of young acute coronary syndrome patients- analysis of 23,560 South Asian patients from 2012 to 2021.
BMC Cardiovasc Disord. 2024 Jul 19;24(1):378. doi: 10.1186/s12872-024-04036-1.
2
Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India.
Cardiol Ther. 2023 Jun;12(2):261-274. doi: 10.1007/s40119-023-00312-x. Epub 2023 Apr 12.
3
Synopsis of Biomarkers of Atheromatous Plaque Formation, Rupture and Thrombosis in the Diagnosis of Acute Coronary Syndromes.
Curr Cardiol Rev. 2022;18(5):53-62. doi: 10.2174/1573403X18666220411113450.
4
Implementation of clinical audit to improve adherence to guideline-recommended therapy in acute coronary syndrome.
Egypt Heart J. 2022 Jan 12;74(1):4. doi: 10.1186/s43044-021-00237-7.
5
Syncytiotrophoblast Extracellular Vesicles from Pre-Eclampsia Placentas Differentially Affect Platelet Function.
PLoS One. 2015 Nov 9;10(11):e0142538. doi: 10.1371/journal.pone.0142538. eCollection 2015.
6
Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: a proteomic study.
PLoS One. 2010 Oct 14;5(10):e13404. doi: 10.1371/journal.pone.0013404.
7
The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients.
Exp Clin Cardiol. 2009 Summer;14(2):e25-30.
8
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
Heart Vessels. 2007 Nov;22(6):361-70. doi: 10.1007/s00380-007-0989-6. Epub 2007 Nov 26.
9
Depression, stress, and coronary heart disease: the need for more complex models.
Heart. 2005 Apr;91(4):419-20. doi: 10.1136/hrt.2004.045310.
本文引用的文献
1
A preferred reperfusion strategy for acute myocardial infarction.
J Am Coll Cardiol. 2003 Dec 3;42(11):1886-9. doi: 10.1016/j.jacc.2003.09.010.
2
Predictors of hospital mortality in the global registry of acute coronary events.
Arch Intern Med. 2003 Oct 27;163(19):2345-53. doi: 10.1001/archinte.163.19.2345.
3
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial.
Lancet. 2003 Sep 6;362(9386):789-97. doi: 10.1016/S0140-6736(03)14287-0.
4
Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE).
Heart. 2003 Sep;89(9):1003-8. doi: 10.1136/heart.89.9.1003.
5
Acute myocardial infarction.
Lancet. 2003 Mar 8;361(9360):847-58. doi: 10.1016/S0140-6736(03)12712-2.
6
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.
Eur Heart J. 2003 Jan;24(1):28-66. doi: 10.1016/s0195-668x(02)00618-8.
7
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.
Lancet. 2003 Jan 4;361(9351):13-20. doi: 10.1016/S0140-6736(03)12113-7.
8
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
Eur Heart J. 2002 Dec;23(23):1809-40. doi: 10.1053/euhj.2002.3385.
9
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).
J Am Coll Cardiol. 2002 Oct 2;40(7):1366-74. doi: 10.1016/s0735-1097(02)02336-7.
10
Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.
Lancet. 2002 Sep 7;360(9335):743-51. doi: 10.1016/s0140-6736(02)09894-x.
Zotero 插件